Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
RubaXX Komplex
- Development stage
- Unknown
- Lead developer
- PharmaSGP
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Administration
- Oral
01
Overview
RubaXX Komplex is a dietary supplement developed by PharmaSGP, designed to support the health and function of cartilage, bones, and connective tissue. It is formulated as a drinkable powder containing a combination of key structural components of joint tissue—including collagen hydrolysate, glucosamine, chondroitin sulfate, and hyaluronic acid—alongside a complex of 20 essential vitamins and minerals (such as vitamins C, D, K, and minerals like manganese, copper, zinc, and magnesium). The supplement is marketed in Europe for daily consumption to maintain joint mobility and overall musculoskeletal health.
- Brand names
- RubaXX ComplexRubaXX Komplex
- Other names
- RubaXX Komplex Trinkpulver
Beyond the preview
Go deeper on RubaXX Komplex.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RubaXX Komplex.